BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) held its Annual General Meeting (“AGM”) today. A total of 92 per cent of the share capital was represented at the virtual assembly. All ...

German vaccine manufacturer BioNTech, which rose to global prominence with its Covid-19 vaccine developed alongside Pfizer, ...

4 Reasons Pfizer Could Be a Value Play You Can't Miss BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to ...

In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German ...

BioNTech is turning to the cost-cutting knife even as it cranks up spending on its late-stage cancer pipeline, a dual strategy that did little to win over the market after last week’s virtual annual ...

The company said it would exit operations at some manufacturing plants in Germany and Singapore, and that as many as 1,860 ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly ...

The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.

Germany s BioNTech said Tuesday it will halt operations at several sites, in a move affecting up to 1,860 jobs, as sales of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

BioNTech is flush with Covid-19 vaccine revenue and it’s putting some of that money to work by acquiring rights to a therapy in the hot area of antibody drug conjugates, or ADCs. It’s the second such ...